Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.
Full description
The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. A secondary objective is to determine the mortality in this critically ill population of individuals.
Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.
Enrollment
Sex
Volunteers
Inclusion criteria
- receiving intravenous lipid emulsion for treatment of a drug toxicity
- Evaluation of a medical toxicologist as part of the ToxIC registry consortium
Exclusion criteria
- not evaluated by a medical toxicologist participating in ToxIC
Trial contacts and locations
Loading...
Central trial contact
michael levine, md
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal